Home » Topics » BioWorld Science

BioWorld Science
RSS

FSH blockade improves cognition in preclinical models of AD

March 7, 2022

Genetic findings pave way to treatment of lymph disorder

March 7, 2022

ATH-1017 positively modulates HGF/MET axis and shows procognitive effects

March 4, 2022

Procoagulant nanoparticles as platelet surrogates for management of bleeding

March 4, 2022

Inhibiting DsbA inactivates resistance enzymes, sensitizing AMR bacteria to existing antibiotics

March 4, 2022

Biomind reports in vivo findings with DMT combination drug BMND-07

March 4, 2022

TRIM14 is a potential therapeutic target for treating inflammation-driven diseases

March 4, 2022

Engineered retinal cells stare daggers at peritoneal tumors

March 4, 2022

Phenanthroline derivative with antitumor activity in liver cancer models

March 4, 2022

Targeting alpha2-Na+/K+ ATPase improves tau pathology in vivo

March 4, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...